Cryofocus Medtech (Shanghai) Co., Ltd. (HKG:6922)
Hong Kong · Delayed Price · Currency is HKD 2.390
+0.010 (0.42%)
Oct 23, 2026, 2:56 PM HKT
HKG:6922 Revenue
Cryofocus Medtech (Shanghai) had revenue of 40.68M CNY in the half year ending June 30, 2026, with 108.88% growth. This brings the company's total for the last twelve months to 84.84M, down -0.38% year-over-year. In the year 2025, Cryofocus Medtech (Shanghai) had annual revenue of 95.27M with 77.97% growth. That makes Cryofocus Medtech (Shanghai) the 36,281st largest company in the world by revenue and 2,204th in Hong Kong.
Revenue (ttm)
84.84M CNY
Revenue Growth
-0.38%
P/S Ratio
5.97
Revenue / Employee
493.26K CNY
Employees
172
Market Cap
584.84M HKD
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 95.27M | 41.74M | 77.97% |
| Dec 31, 2024 | 53.53M | 12.58M | 30.72% |
| Dec 31, 2023 | 40.95M | 13.80M | 50.83% |
| Dec 31, 2022 | 27.15M | 4.72M | 21.06% |
| Dec 31, 2021 | 22.43M | 13.37M | 147.69% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Sisram Medical | 2.91B |
| Austar Lifesciences | 1.86B |
| Gaush Meditech | 1.53B |
| Vincent Medical Holdings | 964.90M |
| Acotec Scientific Holdings | 721.55M |
| MicroPort CardioFlow Medtech | 444.00M |
| Suzhou Basecare Medical Corporation | 300.95M |
| Venus Medtech (Hangzhou) | 294.56M |